Chad Bousman
TitleCited byYear
Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group
S Kelly, N Jahanshad, A Zalesky, P Kochunov, I Agartz, C Alloza, ...
Molecular psychiatry 23 (5), 1261, 2018
Predictors of substance use among homeless youth in San Diego
CA Bousman, EJ Blumberg, AM Shillington, MF Hovell, M Ji, S Lehman, ...
Addictive behaviors 30 (6), 1100-1110, 2005
Kava in the treatment of generalized anxiety disorder: a double-blind, randomized, placebo-controlled study
J Sarris, C Stough, CA Bousman, ZT Wahid, G Murray, R Teschke, ...
Journal of clinical psychopharmacology 33 (5), 643-648, 2013
Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: convergent pathway analysis findings from two independent samples
CA Bousman, G Chana, SJ Glatt, SD Chandler, GR Lucero, E Tatro, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
AB Singh, CA Bousman, CH Ng, K Byron, M Berk
Translational psychiatry 2 (11), e198, 2012
Genetic association studies of methamphetamine use disorders: a systematic review and synthesis
CA Bousman, SJ Glatt, IP Everall, MT Tsuang
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
Commercial pharmacogenetic-based decision-support tools in psychiatry
CA Bousman, M Hopwood
The Lancet Psychiatry 3 (6), 585-590, 2016
Negative mood and sexual behavior among non-monogamous men who have sex with men in the context of methamphetamine and HIV
CA Bousman, M Cherner, C Ake, S Letendre, JH Atkinson, TL Patterson, ...
Journal of affective disorders 119 (1-3), 84-91, 2009
Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis
SJ Glatt, C Bousman, RS Wang, KK Murthy, BK Rana, JA Lasky-Su, ...
Drug and alcohol dependence 90 (2-3), 159-165, 2007
Accelerated gray and white matter deterioration with age in schizophrenia
VL Cropley, P Klauser, RK Lenroot, J Bruggemann, S Sundram, ...
American Journal of Psychiatry 174 (3), 286-295, 2016
White matter disruptions in schizophrenia are spatially widespread and topologically converge on brain network hubs
P Klauser, ST Baker, VL Cropley, C Bousman, A Fornito, L Cocchi, ...
Schizophrenia bulletin 43 (2), 425-435, 2017
Antidepressant pharmacogenetics
AB Singh, CA Bousman, C Ng, M Berk
Current opinion in psychiatry 27 (1), 43-51, 2014
Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood
CA Bousman, G Chana, SJ Glatt, SD Chandler, T May, J Lohr, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 153 …, 2010
Cytochrome P450-2D6 extensive metabolizers are more vulnerable to methamphetamine-associated neurocognitive impairment: preliminary findings
M Cherner, C Bousman, I Everall, D Barron, S Letendre, F Vaida, ...
Journal of the International Neuropsychological Society 16 (5), 890-901, 2010
Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
SJ Glatt, SD Chandler, CA Bousman, G Chana, GR Lucero, E Tatro, ...
Current Pharmacogenomics and Personalized Medicine (Formerly Current …, 2009
Neuregulin-1 and schizophrenia in the genome-wide association study era
MS Mostaid, D Lloyd, B Liberg, S Sundram, A Pereira, C Pantelis, T Karl, ...
Neuroscience & Biobehavioral Reviews 68, 387-409, 2016
Kava for the treatment of generalized anxiety disorder RCT: analysis of adverse reactions, liver function, addiction, and sexual effects
J Sarris, C Stough, R Teschke, ZT Wahid, CA Bousman, G Murray, ...
Phytotherapy Research 27 (11), 1723-1728, 2013
Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
CA Bousman, M Forbes, M Jayaram, H Eyre, CF Reynolds, M Berk, ...
BMC psychiatry 17 (1), 60, 2017
Biomarker investigations related to pathophysiological pathways in schizophrenia and psychosis
G Chana, CA Bousman, TT Money, A Gibbons, P Gillett, B Dean, ...
Frontiers in cellular neuroscience 7, 95, 2013
Effects of oxytocin and genetic variants on brain and behaviour: implications for treatment in schizophrenia
CF Bartholomeusz, EP Ganella, I Labuschagne, C Bousman, C Pantelis
Schizophrenia research 168 (3), 614-627, 2015
The system can't perform the operation now. Try again later.
Articles 1–20